Free Trial

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Sees Large Growth in Short Interest

Bioceres Crop Solutions logo with Consumer Staples background

Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Get Free Report) was the recipient of a large growth in short interest during the month of January. As of January 15th, there was short interest totalling 717,500 shares, a growth of 10.7% from the December 31st total of 648,400 shares. Approximately 2.2% of the shares of the stock are sold short. Based on an average daily volume of 193,500 shares, the days-to-cover ratio is currently 3.7 days.

Bioceres Crop Solutions Stock Down 2.5 %

Shares of NASDAQ:BIOX traded down $0.17 during trading hours on Wednesday, hitting $6.67. The company's stock had a trading volume of 105,717 shares, compared to its average volume of 194,761. Bioceres Crop Solutions has a 52 week low of $5.71 and a 52 week high of $14.05. The firm's fifty day moving average price is $6.69 and its 200 day moving average price is $7.89. The company has a market capitalization of $418.28 million, a price-to-earnings ratio of 333.67 and a beta of 0.57. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.27 and a quick ratio of 0.87.

Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) last posted its quarterly earnings results on Monday, November 11th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.02 by ($0.11). Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.53%. The company had revenue of $92.60 million during the quarter, compared to analysts' expectations of $117.15 million. During the same period in the prior year, the business posted ($0.07) EPS. As a group, research analysts expect that Bioceres Crop Solutions will post 0.12 EPS for the current year.

Wall Street Analyst Weigh In

BIOX has been the topic of a number of recent research reports. Canaccord Genuity Group cut their target price on Bioceres Crop Solutions from $10.00 to $9.50 and set a "buy" rating on the stock in a research note on Wednesday, November 13th. Oppenheimer decreased their target price on Bioceres Crop Solutions from $13.00 to $12.00 and set an "outperform" rating on the stock in a research note on Tuesday, January 28th. Four equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat, Bioceres Crop Solutions currently has an average rating of "Buy" and a consensus target price of $11.88.

View Our Latest Analysis on BIOX

Institutional Investors Weigh In On Bioceres Crop Solutions

Institutional investors have recently bought and sold shares of the company. Dimensional Fund Advisors LP raised its position in Bioceres Crop Solutions by 9.5% in the second quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company's stock valued at $688,000 after purchasing an additional 5,341 shares during the period. Fourth Sail Capital LP increased its position in Bioceres Crop Solutions by 61.6% during the third quarter. Fourth Sail Capital LP now owns 3,171,102 shares of the company's stock worth $24,957,000 after buying an additional 1,209,277 shares during the period. Stifel Financial Corp grew its stake in shares of Bioceres Crop Solutions by 33.4% in the 3rd quarter. Stifel Financial Corp now owns 40,790 shares of the company's stock valued at $321,000 after purchasing an additional 10,224 shares during the last quarter. JPMorgan Chase & Co. lifted its position in Bioceres Crop Solutions by 49.3% in the third quarter. JPMorgan Chase & Co. now owns 89,973 shares of the company's stock valued at $708,000 after purchasing an additional 29,693 shares during the period. Finally, Ping Capital Management Inc. increased its holdings in shares of Bioceres Crop Solutions by 7.3% in the 4th quarter. Ping Capital Management Inc. now owns 44,000 shares of the company's stock valued at $268,000 after purchasing an additional 3,000 shares in the last quarter. 17.68% of the stock is currently owned by institutional investors and hedge funds.

About Bioceres Crop Solutions

(Get Free Report)

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.

Featured Stories

Should You Invest $1,000 in Bioceres Crop Solutions Right Now?

Before you consider Bioceres Crop Solutions, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bioceres Crop Solutions wasn't on the list.

While Bioceres Crop Solutions currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines